Lam Research (LRCX) PT Raised to $310 at UBS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
Lam Research (LRCX) PT Raised to $325 (from $280) at Lynx Equity
April 14, 2026 7:28 AM EDTLam Research (NASDAQ: LRCX) PT Raised to $325 (from $280) at Lynx Equity.
The analyst comments "Since its Investor Day in Feb25 LRCX is up 220% vs AMAT up 135%, ASML up 105% and Sox up 80%. We were long into LRCXs Investor Day when the stock had few takers (link). LRCX continues to be among our favorite ideas. We are raising our PT to $325 from our previous $280 set three months ago, as our visibility stretches out into 2028. We think the stock has priced-in 2026 earnings WFE at $135bn-$140bn is dialed... More
